Medically Reviewed by:Dr. Matthew Stanizzi, MD |
Quick Facts
✅ Semaglutide and Tirzepatide are both used to support weight loss and blood sugar control.
✅ Tirzepatide may lead to greater average weight loss in some studies.
✅ Both medications work by affecting hormones that help control appetite.
✅ Side effects are often related to the stomach and digestive system.
✅ The best option depends on a person’s health needs and medical guidance.
What's In This Guide
- What Is Semaglutide?
- What Is Tirzepatide?
- Tirzepatide vs. Semaglutide for Weight Loss
- Frequently Asked Questions
- Bottom Line
Weight loss medications have become an important part of many treatment plans for people managing overweight or obesity. In recent years, newer medications that affect appetite and metabolism have gained attention for their potential role in supporting weight management alongside lifestyle changes and medical guidance.
Two medications often discussed in this area are Tirzepatide and semaglutide. Both work by affecting hormone signals that help regulate hunger, food intake, and blood sugar levels, which may support weight reduction in some patients.
Here’s a closer look at Tirzepatide vs. semaglutide and how they compare.
What Is Semaglutide?
Semaglutide is a medication used to support blood sugar control and weight management. It works by copying a hormone in the body that helps regulate appetite, which may help people feel full sooner and eat less.
It’s approved by the FDA under three brand names: Ozempic®, Wegovy®, and Rybelsus®. Each one is used for different purposes and comes in different forms and doses. Because of this, it is important to understand which version is being used and how it is prescribed.
How Semaglutide Works for Weight Loss
Semaglutide works by copying a natural hormone in the body called GLP-1. This hormone helps control hunger, slows how fast food leaves the stomach, and helps the body release insulin when needed.
Studies such as the STEP trials have shown that semaglutide may help some people lose weight and improve blood sugar levels. Because of these results, the FDA approved semaglutide for weight management in adults with obesity.
FDA-Approved Uses
Rybelsus® Tablets
Rybelsus® is used to help adults with type 2 diabetes lower blood sugar. It is taken along with healthy eating and exercise.
Ozempic® Injection
Ozempic® is also used to help adults with type 2 diabetes improve blood sugar control. In some adults with type 2 diabetes and known heart disease, it may also help reduce the risk of major cardiovascular events.
Wegovy® Injection
Wegovy® is used for weight loss and weight management in adults with obesity. It may also be used in adults who are overweight and have a related health condition. It is used along with a lower-calorie diet and more physical activity.
Semaglutide Dosage and Administration
How It Is Taken
Semaglutide comes as an injection or a tablet. The injection is given under the skin in the abdomen, thigh, or upper arm. Injection spots should be changed each time.
Available Forms
Semaglutide is sold as Ozempic® and Wegovy® injections and Rybelsus® tablets.
Dosing
Treatment usually starts at a low dose and increases slowly over time. This helps the body adjust and may lower the chance of stomach side effects.
Missed Doses
If a dose is missed, patients usually take the next dose based on the regular schedule. The exact timing can depend on the form being used.
Tablet Instructions
Rybelsus® should be taken on an empty stomach with a small amount of water. It should be taken at least 30 minutes before food, drinks, or other medicines.
Semaglutide Side Effects and Safety
Common Digestive Side Effects
The most common side effects of semaglutide involve the digestive system. These may include nausea, vomiting, stomach pain, diarrhea, or constipation. Some people may also notice reduced appetite or mild stomach discomfort.
Blood Sugar Changes
Semaglutide lowers blood sugar, which may sometimes lead to low blood sugar. This risk may be higher when used with insulin or sulfonylureas.
Kidney and Dehydration Risk
Kidney problems have been reported in some patients, often linked to dehydration from vomiting or diarrhea. Staying hydrated may help lower this risk.
Gallbladder and Pancreas Concerns
Some patients have reported gallbladder problems, such as gallstones or gallbladder inflammation. Cases of pancreatitis have also been reported, though the exact link is still being studied.
Other Possible Effects
Less common side effects may include headache, fatigue, dizziness, rash, or injection-site irritation. In some people with diabetic eye disease, vision symptoms may briefly get worse if blood sugar improves quickly.
Medication Interactions
Semaglutide may slow stomach emptying, which can affect how some oral medicines are absorbed. It should not be used with other GLP-1 medications or Tirzepatide, and other diabetes medicine doses may need adjustment to lower the risk of low blood sugar.
What Is Tirzepatide?
Tirzepatide is a newer medication that may support weight loss and blood sugar balance. It works with two hormone signals in the body, which can help reduce hunger, lower food intake, and support metabolic function.
Tirzepatide is approved in several countries, including the United States, the European Union, and Japan. It is given as a once-weekly injection under the skin and is used to help manage type 2 diabetes. In the United States and the United Kingdom, it is also approved for the treatment of obesity.
How Tirzepatide Works for Weight Loss
Tirzepatide works on two hormone signals in the body called GLP-1 and GIP. These hormones help control appetite, blood sugar, and how the body uses energy.
Research studies, including the SURMOUNT trials, found that Tirzepatide may support weight loss and better blood sugar control in some people.
Tirzepatide Dosage and Administration
How Tirzepatide Is Given
Tirzepatide is given as an injection under the skin. It is usually taken once a week. At this time, it is not available as a pill.
Available Dose Strengths
Tirzepatide comes in several dose strengths. These include 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg per injection.
Typical Dosing Schedule
Tirzepatide usually starts at 2.5 mg once a week. After about four weeks, the dose may increase to 5 mg once weekly. If needed, it may be increased slowly over time based on response and tolerance. The highest approved dose is 15 mg once a week.
If a dose is missed, it may be taken within four days when possible. After that, the missed dose is usually skipped and the regular schedule is continued.
Considerations for Certain Patients
People with liver problems usually do not need a dose change. Those with kidney concerns may need closer monitoring, especially if side effects like nausea, vomiting, or diarrhea lead to dehydration.
There is limited information on Tirzepatide use during pregnancy or breastfeeding. It has also not been confirmed as safe or effective for children. Older adults may respond similarly to younger adults, but monitoring may still be needed.
Tirzepatide Side Effects and Safety
Common Stomach-Related Side Effects
The most common side effects of Tirzepatide are related to the stomach and digestive system. These may include nausea, diarrhea, vomiting, acid reflux, and constipation. Some people also report a lower appetite, which may be part of how the medication supports weight loss.
Other Possible Side Effects
Less common side effects may include a faster heart rate, injection-site irritation, and problems linked to dehydration, especially if vomiting or diarrhea is severe.
Kidney and Dehydration Concerns
Dehydration from stomach-related side effects may sometimes lead to kidney problems. This risk may be higher in people with kidney disease or those prone to fluid loss.
Pancreas and Gallbladder Warnings
Tirzepatide may carry a risk of pancreatitis. Gallbladder problems, such as gallstones or gallbladder inflammation, have also been reported. Severe stomach pain should be discussed with a clinician right away.
Blood Sugar and Vision Changes
A small risk of low blood sugar can happen, especially in people who also use insulin or certain diabetes medicines. In some people with diabetic eye disease, vision symptoms may briefly worsen if blood sugar improves quickly.
Overall Safety
Available research suggests Tirzepatide has a safety profile similar to other GLP-1 medications. Higher doses may be more likely to cause side effects like nausea, vomiting, diarrhea, low blood sugar, or injection-site reactions.
Medication Interactions
Tirzepatide should not be used with other GLP-1 medications, such as semaglutide or liraglutide. It may also affect insulin dosing, lower the effectiveness of oral birth control pills, and slow stomach emptying, which can change how some oral medicines are absorbed.
Tirzepatide vs. Semaglutide for Weight Loss
Researchers have compared Tirzepatide and semaglutide in people with overweight or obesity to see how well each medication supports weight loss. Both drugs affect appetite and blood sugar, so they are often studied side by side in weight management research.
Results From a Large Real-World Study
One large study looked at adults with overweight or obesity who were taking either Tirzepatide or semaglutide in U.S. health systems. The study found that people taking Tirzepatide were more likely to reach weight loss goals such as 5%, 10%, and 15% of body weight. It also showed greater average weight loss with Tirzepatide at 3, 6, and 12 months.
Findings From Multiple Clinical Trials
Another study combined data from 28 clinical trials to compare the two medications. In that analysis, Tirzepatide showed greater reductions in body weight, BMI, waist size, and blood sugar levels than semaglutide. These findings suggest Tirzepatide may lead to stronger overall weight-related changes in some patients.
Conclusions From a Meta-Analysis
A separate meta-analysis that included two randomized trials and five retrospective cohort studies also found greater weight loss with Tirzepatide than with semaglutide. The analysis suggested that weight loss with Tirzepatide appeared stronger at higher doses and with longer treatment duration. The authors also reported that the included studies were generally high quality and had a low risk of bias.
Frequently Asked Questions (FAQs)
Which medication works better for weight loss?
Some studies suggest Tirzepatide may lead to greater average weight loss compared with semaglutide in certain groups of patients. However, responses can vary depending on individual health factors, treatment plans, and lifestyle changes.
Are semaglutide and Tirzepatide the same type of drug?
Both medications affect hormones that regulate appetite and blood sugar. Semaglutide works on the GLP-1 pathway, while Tirzepatide acts on both GLP-1 and GIP pathways.
Do these medications work without diet and exercise?
These medications are typically prescribed along with lifestyle changes such as healthy eating and physical activity. They are usually part of a broader weight management approach.
Can someone take semaglutide and Tirzepatide together?
No. These medications are not meant to be used together because they act on similar hormone pathways.
How long do people usually take these medications?
The length of treatment can vary depending on individual health goals and medical guidance. Ongoing monitoring by a healthcare provider is usually recommended.
Bottom Line
Both semaglutide and Tirzepatide are medications that may help support weight loss and blood sugar control in selected patients. Research comparing the two suggests Tirzepatide may lead to greater average weight reduction in some studies, although responses vary between individuals. Because these medications can work differently from person to person, treatment decisions should be based on medical history, health goals, and guidance from a qualified healthcare provider.
BioRestore Health also offers Compounded Non-FDA Approved GLP-1 as part of its medical weight loss program. This option is provided with clinical oversight and may be considered as part of a broader treatment approach for weight management. It is not guaranteed, is not a substitute for standard medical care, and should be discussed with a licensed physician.
DISCLAIMER:
This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Results can vary from person to person. Always consult with a qualified healthcare provider before starting or changing any medication.
SOURCES:
Kommu, S., & Whitfield, P. (2024). Semaglutide. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK603723/
Aronne, L. J., Sattar, N., Horn, D. B., et al. (2024). Continued treatment with Tirzepatide for maintenance of weight reduction in adults with obesity: The SURMOUNT-4 randomized clinical trial. JAMA, 331(1), 38–48. https://jamanetwork.com/journals/jama/fullarticle/2812936
Bernardi, J. C., Cavalcante, D. V. S., Huntermann, R., Molinari, M. E., Zanon, L. Z., Khater, J., Gomez, V. A., & Fischer-Bacca, C. O. (2026). Who wins the battle against obesity? A network meta-analysis comparing tirzepatide and semaglutide. Journal of Diabetes, 18(2), e70192. https://pmc.ncbi.nlm.nih.gov/articles/PMC12887578/
Farzam, K., & Patel, P. (2024). Tirzepatide. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK585056/
Rodriguez, P. J., Goodwin Cartwright, B. M., Gratzl, S., et al. (2024). Semaglutide vs Tirzepatidefor weight loss in adults with overweight or obesity. JAMA Internal Medicine, 184(9), 1056–1064. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2821080
Aamir, A. B., Latif, R., Alqoofi, J. F., Almarzoq, F. A., Fallatah, J. O., Hassan, G. A., & Saab, F. A. A. A. A. (2025). Comparative efficacy of tirzepatide vs. semaglutide in reducing body weight in humans: A systematic review and meta-analysis of clinical trials and real-world data. Journal of Clinical Medicine Research, 17(5), 285–296. https://pmc.ncbi.nlm.nih.gov/articles/PMC12151102/